Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
Cancer
|
April 7, 2009
Reflex UroVysion testing in suspicious urine cytology cases
Susana Ferra, Ryan Denley, Harry Herr, et al.
Urologic Oncology
|
December 30, 2008
Optimizing outcomes at every stage of bladder cancer: do we practice it?
Harry Herr, Badrinath Konety, John Stein, et al.
The Journal of Urology
|
April 12, 2005
Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer?
Jason Hafron, Nandita Mitra, Guido Dalbagni, et al.
Urologic Oncology
|
July 18, 2015
Re: Herr et al.: BCG-refractory vs. BCG-relapsing non-muscle-invasive bladder cancer: A prospective cohort outcomes study (Urol Oncol 2015; 33: 108.el-108.e4)
Alvaro Morales, Ashish Kamat, Gary Steinberg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
October 4, 2008
Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF
Padmanee Sharma, Dean F Bajorin, Achim A Jungbluth, et al.
Journal of the National Cancer Institute
|
April 17, 2003
Adherence to surveillance among patients with superficial bladder cancer
Deborah Schrag, Lillian J Hsieh, Farhang Rabbani, et al.
The Journal of Urology
|
October 7, 2014
Efficacy and safety of MCNA in patients with nonmuscle invasive bladder cancer at high risk for recurrence and progression after failed treatment with bacillus Calmette-Guérin
Alvaro Morales, Harry Herr, Gary Steinberg, et al.
The Canadian Journal of Urology
|
October 4, 2017
Improving the quality of operative reports for transurethral resection of bladder tumor surgery in resident education
Joseph Haddad, Christopher Anderson, Jonathan Heinlen, et al.
Urology
|
June 1, 2005
Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population
Deborah Schrag, Nandita Mitra, Feng Xu, et al.
The Journal of Urology
|
March 27, 2007
Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer
Ganesh V Raj, Harry Herr, Angel M Serio, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
Cancer
|
April 7, 2009
Reflex UroVysion testing in suspicious urine cytology cases
Susana Ferra, Ryan Denley, Harry Herr, et al.
Urologic Oncology
|
December 30, 2008
Optimizing outcomes at every stage of bladder cancer: do we practice it?
Harry Herr, Badrinath Konety, John Stein, et al.
The Journal of Urology
|
April 12, 2005
Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer?
Jason Hafron, Nandita Mitra, Guido Dalbagni, et al.
Urologic Oncology
|
July 18, 2015
Re: Herr et al.: BCG-refractory vs. BCG-relapsing non-muscle-invasive bladder cancer: A prospective cohort outcomes study (Urol Oncol 2015; 33: 108.el-108.e4)
Alvaro Morales, Ashish Kamat, Gary Steinberg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
October 4, 2008
Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF
Padmanee Sharma, Dean F Bajorin, Achim A Jungbluth, et al.
Journal of the National Cancer Institute
|
April 17, 2003
Adherence to surveillance among patients with superficial bladder cancer
Deborah Schrag, Lillian J Hsieh, Farhang Rabbani, et al.
The Journal of Urology
|
October 7, 2014
Efficacy and safety of MCNA in patients with nonmuscle invasive bladder cancer at high risk for recurrence and progression after failed treatment with bacillus Calmette-Guérin
Alvaro Morales, Harry Herr, Gary Steinberg, et al.
The Canadian Journal of Urology
|
October 4, 2017
Improving the quality of operative reports for transurethral resection of bladder tumor surgery in resident education
Joseph Haddad, Christopher Anderson, Jonathan Heinlen, et al.
Urology
|
June 1, 2005
Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population
Deborah Schrag, Nandita Mitra, Feng Xu, et al.
The Journal of Urology
|
March 27, 2007
Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer
Ganesh V Raj, Harry Herr, Angel M Serio, et al.
Page
of 7